Offering a gentle and superior alternative to hydroquinone-based formulations, Enlighten by Evidence Skincare (ESK) uses an exclusive and clinically approved tyrosinase inhibitor, 4-n-Butylresorcinol (4nB), to lighten pigmentation and reduce future melanin deposits. Combining antioxidant multitasker, niacinamide (vitamin B3), Enlighten also helps to balance sebum production, improve the skin’s moisture barrier, and increase collagen synthesis for firmer, younger-looking skin. Providing results in as little as six weeks, Enlighten is suitable for daily and long-term use and is safe for pregnant and breastfeeding women. To learn more about Evidence Skincare (ESK) and their range of cosmeceutical-grade skincare systems, please visit www.eskcare.com
ENTER TO WIN
Canberra Weekly has 3 x Enlighten by ESK to be won, valued at $95 each.
To enter, email [email protected] with ‘Enlighten by ESK’ in the subject field. Tell us your name, full contact details (including best delivery address) and one of the ingredients in Enlighten by ESK. Entries close 9am Friday 8 January 2021 and winners drawn same day. One entry per person. Entrants must be aged 18+.
Enter our other competitions: